Stock Radar:Buy Zydus Lifesciences for a target of Rs 435 in next 3-4 weeks, says Gaurav Bissa
Zydus Lifesciences is showing a strong relative strength chart against Nifty500 wherein it has bounced strongly from major support signally strong outperformance in coming weeks, Gaurav Bissa, VP, InCred Equities, said.
READ MORE:
Other News Videos
LIVE | Adani Group Annual General Meeting 2026: Chairman Gautam Adani's address
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut